Literature DB >> 11261650

Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patients.

H J Haug1, A Wirz-Justice, W Rössler.   

Abstract

OBJECTIVE: A component of social skills is the ability to adapt to the social rhythms of the environment. Patients with schizophrenia are often disabled in this adaptation. Thus, structuring activities throughout the day has long been known as part of psychosocial treatments. Actigraphy as a tool to measure acitvity and circadian rhythms may even serve as an indicator for the day-structuring of schizophrenic patients.
METHOD: Actigraphy was used in a patient with affective disorder and one with chronic schizophrenia for more than 2 weeks.
RESULTS: In comparison to a regular 24-hour rest-activity cycle in a depressed patient, the actigraph of the patient with schizophrenia presents active phases at night, irregular activity levels at day and signs of a delayed-sleep-phase syndrome.
CONCLUSION: Actigraphy could serve as a tool to investigate activity levels and circadian rest-activity phases, even in schizophrenia. There may be some further benefit of actigraphy as a tool in psychosocial treatments.

Entities:  

Mesh:

Year:  2000        PMID: 11261650     DOI: 10.1034/j.1600-0447.2000.00018.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  9 in total

1.  Actigraphy studies and clinical and biobehavioural correlates in schizophrenia: a systematic review.

Authors:  Zi Ying Wee; Samantha Wei Lee Yong; Qian Hui Chew; Cuntai Guan; Tih Shih Lee; Kang Sim
Journal:  J Neural Transm (Vienna)       Date:  2019-03-19       Impact factor: 3.575

2.  Spontaneous arm movement activity assessed by accelerometry is a marker for early recovery after stroke.

Authors:  Rüdiger J Seitz; Tim Hildebold; Karin Simeria
Journal:  J Neurol       Date:  2010-10-16       Impact factor: 4.849

3.  Association of polymorphism in the promoter of the melatonin receptor 1A gene with schizophrenia and with insomnia symptoms in schizophrenia patients.

Authors:  Hae Jeong Park; Jin Kyung Park; Su Kang Kim; Ah-Rang Cho; Jong Woo Kim; Sung-Vin Yim; Joo-Ho Chung
Journal:  J Mol Neurosci       Date:  2011-04-28       Impact factor: 3.444

Review 4.  Clinical application of actigraphy in psychotic disorders: a systematic review.

Authors:  Masoud Tahmasian; Habibolah Khazaie; Sanobar Golshani; Kristin T Avis
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

5.  Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.

Authors:  Michael Kiang; Z Jeff Daskalakis; Bruce K Christensen; Gary Remington; Shitij Kapur
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

6.  Ambulatory sleep-wake patterns and variability in young people with emerging mental disorders.

Authors:  Rébecca Robillard; Daniel F Hermens; Sharon L Naismith; Django White; Naomi L Rogers; Tony K C Ip; Sharon J Mullin; Gail A Alvares; Adam J Guastella; Kristie Leigh Smith; Ye Rong; Bradley Whitwell; James Southan; Nick Glozier; Elizabeth M Scott; Ian B Hickie
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

7.  Sleep and circadian rhythm disruption in schizophrenia.

Authors:  Katharina Wulff; Derk-Jan Dijk; Benita Middleton; Russell G Foster; Eileen M Joyce
Journal:  Br J Psychiatry       Date:  2011-12-22       Impact factor: 9.319

8.  Comparison of actigraphy indices among patients with depression and schizophrenia: A preliminary study.

Authors:  Ramdas Ransing; Pradeep Patil; Swaroopa Patil; Shruti Agrawal
Journal:  J Family Med Prim Care       Date:  2021-09-30

9.  Quality of sleep in patients with schizophrenia is associated with quality of life and coping.

Authors:  John R Hofstetter; Paul H Lysaker; Aimee R Mayeda
Journal:  BMC Psychiatry       Date:  2005-03-03       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.